177 research outputs found
Educazione sanitaria sugli effetti della guerra: progetto pilota di comunicazione scientifica nelle scuole
Deaths and injuries are the most immediate effects of war, but war also causes living conditions to fall below minimum levels, favours the spread of disease and makes health interventions difficult. Thus the first victims of modern war are civilians. A communication project aimed at raising awareness among youth on the effects of conflicts on the health conditions of the population has been developed. Three case studies have been identified: acute emergency (Darfur), chronic conflict (Palestine), historic conflict (Vietnam) - collecting scientific documentation on the health effects of war in these countries. Three school modules have been developed, providing the students with extracurricular scientific tools for dealing with the subject "war and health". This document describes the implementation of the modules on a class of secondary school and offers suggestions for further implementations by epidemiologists and teachers
Restless legs syndrome: differential diagnosis and management with rotigotine
RLS is a common sleep disorder with distinctive clinical features. The prevalence of RLS in Caucasians and North Americans ranges from 5% to 10%. However, only some of these subjects (almost the 3% of the general population) report being affected by a frequent and severe form of the sleep disorder. RLS is diagnosed clinically by means of four internationally recognized criteria that summarize the main characteristics of the sleep disorder. Besides the essential criteria, supportive and associated features of RLS have been established by experts in order to help physicians treat patients with doubtful symptoms. Several clinical conditions may mimic this sleep disorder. In order to increase the sensibility and specificity of RLS diagnosis, doctors should perform a meticulous patient history and then an accurate physical and neurological examination. Dopamine agonists are recognized as the preferred first-line treatment for RLS. Rotigotine is a non-ergoline dopamine agonist with selectivity for D1, D2 and D3 receptors. The drug is administered via transdermal patches which release rotigotine for 24 hours. Four clinical trials demonstrated that this compound is able to improve RLS symptomatology with few and moderate adverse events. Head to head trials are required to compare the efficacy and tolerability of rotigotine with other dopamine agonists administered via oral intake. Rotigotine has been approved by the FDA and EMEA for Parkinson’s disease. For the treatment of moderate to severe idiopathic RLS, rotigotine has been recommended for approval by the EMEA and is under review by the FDA
Pulsed laser deposition of a dense and uniform Au nanoparticles layer for surface plasmon enhanced efficiency hybrid solar cells
n/
Graded vertical phase separation of donor/acceptor species for polymer solar cells
The donor/acceptor inter-mixing in bulk heterojunction (BHJ) solar cells is a critical parameter, often leading to irreproducible performance of the finished device. An alternative solution-processed device fabrication strategy towards a better control of the micro/nano-structured morphology consists of a sequential coating of the donor (e.g., poly-(3-hexylthiophene), P3HT) and the acceptor (e.g., [6,6]-phenyl-C61-butyric acid methyl ester, PCBM) from orthogonal solvents. We demonstrate that, in spite of the solvent orthogonality, this technique does not lead to a well-defined bilayer with a sharp interface, but it rather results in a graded vertical phase-separated junction, resulting from the diffusion of the PCBM in the P3HT bottom layer. We are able to control the diffusion of PCBM, which occurs preferentially in the amorphous P3HT domains, by easily varying the ratio between crystalline/amorphous domains in the P3HT. Such a ratio can be simply modified by changing the solvent for P3HT. We show that the donor–acceptor diffused bilayer (DB) junction is an intermediate structure which combines both advantages of the well-defined bilayer and conventional BHJ configurations. Indeed, the DB device geometry ensures the good reproducibility and charge percolation, like the well-defined bilayer, while preserving the interpenetration of the donor and acceptor species, resulting in an efficient charge separation, characteristic of the BHJ. Overall the annealed DB device geometry can be assimilated to a graded BHJ with an improved reproducibility and mean power conversion efficiency (PCE) of 3.45%, higher than that of the standard BHJ devices of 3.07%. Furthermore, we demonstrate the highest performance for the as-cast DB device with a PCE of 2.58%. It is worthy to note that our DB device exhibits improved open circuit voltage, fill factor, series and shunt resistances, which denote that the vertically phase separated DB junction ensures improved charge percolation
Seizures Do Not Affect Disability and Mortality Outcomes of Stroke: A Population-Based Study
Although seizures are frequently seen after cerebrovascular accidents, their effects on long-term outcome in stroke patients are still unknown. Therefore, the aim of this study was to investigate the relationship between post-stroke seizures and the risk of long-term disability and mortality in stroke patients. This study is part of a larger population-based study. All patients were prospectively followed up by a face-to-face interview or a structured telephone interview. We enrolled 635 patients with first-ever stroke and without a history of seizures. Prevalence of ischemic stroke (IS) was 85.2%, while the remaining 14.8% of patients were affected by intracerebral hemorrhage (ICH). During the study period, 51 subjects (8%) developed post-stroke seizures. Patients with post-stroke seizures were younger, had a higher prevalence of ICH, had a more severe stroke at admission, were more likely to have an IS involving the total anterior circulation, and were more likely to have a lobar ICH than patients without seizures. Moreover, subjects with seizures had more frequently hemorrhagic transformation after IS and cortical strokes. At 24 months, the risk of disability in patients with seizures was almost twice than in those without seizures. However, the negative effect of seizures disappeared in multivariate analysis. Kaplan-Meier survival curves at 12 years were not significantly different between patients with and without post-stroke seizures. Using the Cox multivariate analysis, age, NIHSS at admission, and pre-stroke mRS were independently associated with all-cause long-term mortality. In our sample, seizures did not impair long-term outcome in patients affected by cerebrovascular accidents. The not significant, slight difference in favor of a better survival for patients with seizures may be attributed to the slight age difference between the two groups
Synthesis and Photovoltaic Properties of Regioregular Head-to-Head Substituted Thiophene Hexadecamers
n/
Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
BACKGROUND:
Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis.
METHODS:
Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software.
RESULTS:
In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n\u2009=\u2009305,044), while 42% of prevalent women had breast cancer (n\u2009=\u2009604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since 6515 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+\u200937% vs 2010). The largest 10-year increases are foreseen for prostate (+\u200985%) and for thyroid cancers (+\u200979%), and for long-term survivors diagnosed since 20 or more years (+\u200945%). Among the population aged 6575 years, 22% will have had a previous cancer diagnosis.
CONCLUSIONS:
The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation need
- …